https://www.youtube.com/watch?v=ECd3N-qiOMo Key highlights from Prevest Denpro Limited (PREVEST) Q3 FY22 Earnings Concall Q&A Highlights: Pranay Jain from Dealwell Capital asked that since
Categories
Health Care
Cupid Limited Q3 FY22 Earnings Conference Call Insights
https://youtu.be/bwoNY3Y0LHo Key highlights from Cupid Limited (CUPID) Q3 FY22 Earnings Concall Management Update: CUPID stated that the top and bottom line performance
Orchid Pharma Ltd Q3 FY22 Earnings Conference Call Insights
https://www.youtube.com/watch?v=z2DK9xz1c8k Key highlights from Orchid Pharma Ltd (ORCHPHARMA) Q3 FY22 Earnings Concall Q&A Highlights: Viraj Kacharia from Securities Investment asked about the
JB Chemicals & Pharmaceuticals Limited Q3 FY22 Earnings Conference Call Insights
https://www.youtube.com/watch?v=HiVTF6vv9q0 Key highlights from JB Chemicals & Pharmaceuticals Limited (JBCHEPHARM) Q3 FY22 Earnings Concall Management Update: The company outperformed the sector with
MedPlus Health Services Ltd Q3 FY22 Earnings Conference Call Insights
https://www.youtube.com/watch?v=z_QNho0XdFU Key highlights from MedPlus Health Services Ltd (MEDPLUS) Q3 FY22 Earnings Concall Management Update: The company opened over 537 stores in
Glenmark Pharmaceuticals Limited Q3 FY22 Earnings Conference Call Insights
https://www.youtube.com/watch?v=Mzpw87FqOBE Key highlights from Glenmark Pharmaceuticals Limited (GLENMARK) Q3 FY22 Earnings Concall Management Update: GLENMARK stated the India business continues to outperform
Sequent Scientific Limited Q3 FY22 Earnings Conference Call Insights
https://www.youtube.com/watch?v=iqM668J91yY Key highlights from Sequent Scientific Limited (SEQUENT) Q3 FY22 Earnings Concall Management Update: SEQUENT saw significant improvement in the API order
Divi’s Laboratories Ltd Q3 FY22 Earnings Conference Call Insights
https://www.youtube.com/watch?v=E7EoiAKzMn0 Key highlights from Divi's Laboratories Ltd (DIVISLAB) Q3 FY22 Earnings Concall Management Update: The company capitalized INR196 crores in 3Q22 and
Apollo Hospitals Enterprise Ltd (APOLLOHOSP) Q3 FY22 Earnings Concall Transcript
Apollo Hospitals Enterprise Limited (NSE: APOLLOHOSP) Q3 FY22 Earnings Concall dated Feb. 12, 2022 Corporate Participants: Mayank Vaswani -- Investor Relations Suneeta Reddy -- Managing Director Dr.
Divi’s Laboratories Ltd (DIVISLAB) Q3 FY22 Earnings Conference Call Transcript
Divi's Laboratories Ltd (NSE: DIVISLAB) Q3 FY22 Earnings Concall dated Feb. 11, 2022 Corporate Participants: M. Satish Choudhury -- Company Secretary and Compliance Officer
Piramal Enterprises Ltd (PEL) Q3 FY22 Earnings Concall Transcript
Piramal Enterprises Ltd (NSE : PEL) Q3 FY22 Earnings Concall dated Feb. 10, 2022, Corporate Participants: Hitesh Dhaddha -- Chief Investor Relations
Dr Lal PathLabs Ltd Q3 FY22 Earnings Conference Call Insights
https://www.youtube.com/watch?v=q_lILVipT-E Key highlights from Dr Lal PathLabs Ltd (LALPATHLAB) Q3 FY22 Earnings Concall Management Update: The company is enhancing access of its
Piramal Enterprises Ltd Q3 FY22 Earnings Conference Call Insights
https://www.youtube.com/watch?v=Wh0LRTM3LTg Key highlights from Piramal Enterprises Ltd (PEL) Q3 FY22 Earnings Concall Management Update: In financial service, PEL said it plans to
Aurobindo Pharma Limited (AUROPHARMA) Q3 FY22 Earnings Concall Transcript
Aurobindo Pharma Limited (NSE :AUROPHARMA) Q3 2022 Earnings Concall Feb. 10, 2022, Corporate Participants: Arvind Bothra -- Investor Relations Department Santhanam Subramanian
Cadila Healthcare Ltd (CADILAHC) Q3 FY22 Earnings Concall Transcript
Cadila Healthcare Limited (NSE:CADILAHC) Q3 FY22 Earnings Concall dated Feb. 03, 2022 Corporate Participants: Ganesh Nayak -- Executive Sharvil P. Patel --
IPO Alert: Rainbow Children’s Medicare Limited files for initial public offering
The estimated size of the hospital market in India was ₹4,270 billion in the fiscal year 2020, representing an annual growth of
Jubilant Ingrevia Ltd Q3 FY22 Earnings Conference Call Insights
https://www.youtube.com/watch?v=VEV5IjVrTNI Key highlights from Jubilant Ingrevia Ltd (JUBLINGREA) Q3 FY22 Earnings Concall Management Update: JUBLINGREA commented that with its capex plans shaping
Sun Pharmaceutical Industries Ltd (SUNPHARMA) Q3 FY22 Earnings Concall Transcript
Sun Pharmaceutical Industries Limited (NSE: SUNPHARMA) Q3 FY22 Earnings Concall dated Jan. 31, 2022 Corporate Participants: Nimish Desai -- Head of Investor Relations Dilip
Infographic: Key highlights from Sun Pharma Q3 2022 earnings results
Sun Pharmaceutical Industries (NSE: SUNPHARMA) reported its third-quarter 2022 earnings results today. The company reported consolidated revenue of ₹10,295 crores with a growth of
Cipla Limited (CIPLA) Q2 FY22 Research Summary
The pharma giant Cipla's net profit rose 7.57% year-on-year (YoY) to Rs 712 crore for Q2 FY22. Cipla market research report covers
Torrent Pharmaceuticals Ltd (TORNTPHARM) Q3 FY22 Earnings Concall Transcript
Torrent Pharmaceuticals Ltd (NSE: TORNTPHARM) Q3 FY22 Earnings Concall dated Jan. 25, 2022 Corporate Participants: Sudhir Menon -- Executive Director and Chief Financial Officer